全文获取类型
收费全文 | 1368篇 |
免费 | 105篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 68篇 |
妇产科学 | 129篇 |
基础医学 | 155篇 |
口腔科学 | 65篇 |
临床医学 | 133篇 |
内科学 | 249篇 |
皮肤病学 | 31篇 |
神经病学 | 42篇 |
特种医学 | 141篇 |
外科学 | 164篇 |
综合类 | 37篇 |
预防医学 | 86篇 |
眼科学 | 29篇 |
药学 | 78篇 |
中国医学 | 3篇 |
肿瘤学 | 62篇 |
出版年
2023年 | 11篇 |
2022年 | 29篇 |
2021年 | 45篇 |
2020年 | 16篇 |
2019年 | 20篇 |
2018年 | 40篇 |
2017年 | 19篇 |
2016年 | 36篇 |
2015年 | 43篇 |
2014年 | 34篇 |
2013年 | 46篇 |
2012年 | 71篇 |
2011年 | 63篇 |
2010年 | 52篇 |
2009年 | 62篇 |
2008年 | 73篇 |
2007年 | 72篇 |
2006年 | 52篇 |
2005年 | 48篇 |
2004年 | 54篇 |
2003年 | 32篇 |
2002年 | 44篇 |
2001年 | 27篇 |
2000年 | 24篇 |
1999年 | 27篇 |
1998年 | 39篇 |
1997年 | 42篇 |
1996年 | 32篇 |
1995年 | 21篇 |
1994年 | 24篇 |
1993年 | 19篇 |
1992年 | 12篇 |
1991年 | 17篇 |
1990年 | 14篇 |
1989年 | 26篇 |
1988年 | 23篇 |
1987年 | 19篇 |
1986年 | 15篇 |
1985年 | 18篇 |
1984年 | 7篇 |
1983年 | 11篇 |
1982年 | 9篇 |
1980年 | 17篇 |
1977年 | 10篇 |
1976年 | 10篇 |
1975年 | 11篇 |
1974年 | 11篇 |
1973年 | 12篇 |
1971年 | 5篇 |
1969年 | 6篇 |
排序方式: 共有1497条查询结果,搜索用时 15 毫秒
21.
22.
Role for Fimbriae and Lysine-Specific Cysteine Proteinase Gingipain K in Expression of Interleukin-8 and Monocyte Chemoattractant Protein in Porphyromonas gingivalis-Infected Endothelial Cells 总被引:3,自引:0,他引:3 下载免费PDF全文
23.
Membrane expression of platelet calpain 总被引:1,自引:1,他引:1
Platelet calpain has many platelet substrates, including external membrane proteins. We thus investigated whether platelet calpain II was associated with platelet membranes in unstimulated and thrombin- activated platelets. A monospecific, goat polyclonal antibody was reared to purified platelet calpain II. Sixteen whole platelet lysates were found to contain 4.5 +/- 0.7 micrograms calpain antigen II per 10(8) platelets (mean +/- SEM) as determined by a competitive enzyme- linked immunosorbent assay. Using the dipeptide fluorogenic substrate, Suc-Leu-Tyr-MCA, 17 human platelet lysates contained 3.6 +/- 0.4 micrograms calpain activity per 10(8) platelets. Platelet calpain II was associated with the Triton X-100 insoluble platelet cytoskeletons from both unstimulated and thrombin-activated platelets. When compared with the total cell content of platelet calpain II, calpain antigen (10% to 13%) and calpain activity (24% to 28%) was associated with platelet cytoskeletons in unstimulated and thrombin-activated platelets, respectively. On immunoblot, the heavy chain (80 Kd) of calpain II was detected in platelet cytoskeletons. Subcellular fractionation studies on both unstimulated and thrombin-activated platelets, revealed that half of the total platelet calpain II antigen was associated with cytosol, and the other half was associated with the membrane fraction. Platelet calpain II was not seen on the surface of unstimulated, paraformaldehyde fixed platelets by immunofluorescence. However, on thrombin-activated platelets, rim immunofluorescence was seen, indicating that activated platelets externalize their calpain. This observation was confirmed by the finding that about 2,000 molecules per platelet of an 125I-anti-calpain II Fab' specifically bound to thrombin-activated but not unstimulated platelets. Both dibucaine (1 mmol/L) and platelet activating factor (1.86 mumol/L) in the absence of external Ca++, but not collagen (5 micrograms/mL) or ionophore A23187 (2.5 mumol/L) in the absence of external Ca++, were also able to externalize platelet calpain II antigen, as indicated by a similar level of specific 125I-anti-calpain II Fab'-platelet binding. These combined studies indicate that platelet calpain II is a major protein, comprising 2% of total platelet protein, a substantial portion of which is membrane-associated. When platelets are activated by thrombin and platelet activating factor, calpain II antigen also becomes present on the external platelet surface. 相似文献
24.
Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome 总被引:1,自引:0,他引:1
Abuzeid MI Nassar Z Massaad Z Weiss M Ashraf M Fakih M 《Human reproduction (Oxford, England)》2003,18(2):370-373
BACKGROUND: Severe ovarian hyperstimulation syndrome (OHSS) is potentially dangerous. The study aim was to evaluate the efficacy and safety of percutaneous pigtail catheter drainage for the management of ascites complicating severe OHSS. METHODS: This was a prospective trial conducted at a private IVF centre and a tertiary teaching medical centre. A total of 26 patients with severe OHSS was recruited. Patients were divided into two groups. Patients in group 1 (n = 13) were hospitalized, while patients in group 2 (n = 13) were managed on an outpatient basis. A pigtail catheter was inserted under transabdominal ultrasound guidance and kept in place until drainage ceased. The main outcome measures were resolution of OHSS as determined by symptomatology and laboratory values, time to removal of catheter, patient tolerance of the procedure and complication rate. RESULTS: The catheter was successfully placed in all patients following one attempt and was kept in place for a mean +/- SD of 12.9 +/- 4.3 days (range 7-24). Average amount of fluid drained was 11.2 +/- 4.3 l (range: 3.35-18.5). An improvement of symptoms and signs was noted 24-48 h after catheter placement in all patients in both groups. Procedure was well tolerated and no complications reported. CONCLUSIONS: Percutaneous placement of a pigtail catheter is a safe and effective treatment modality for severe OHSS. It may represent an attractive alternative to multiple vaginal or abdominal paracentesis. 相似文献
25.
MD Kinsella A Nassar MT Siddiqui C Cohen 《International journal of clinical and experimental pathology》2012,5(6):530-536
Background
The estrogen receptor (ER), progesterone receptor (PR), and HER2 profile of a primary breast carcinoma plays a significant role in patient management and treatment. Because of the increasing utilization of neoadjuvant chemotherapy or hormone therapy, surgically-resected carcinomas often show marked treatment effect. The aim of this study was to compare immunohistochemical (IHC) profiles (ER, PR, HER2, HER2 FISH) of primary breast carcinomas before and after neoadjuvant chemotherapy to assess the subsequent effects on hormone receptor status.Design
Primary breast carcinomas from 38 female patients treated with neoadjuvant therapy after needle core biopsy or fine needle aspiration diagnosis were included. Histologic data was collected for each case, including site, type, grade, tumor size (cm), pre- and post- neoadjuvant treatment IHC panel (ER, PR, HER2), and fluorescence in-situ hybridization (FISH) for HER2.Results
Of the 38 carcinomas studied, 45 % were positive for ER by IHC both pre- and post- neoadjuvant treatment (P=1.00). IHC studies for PR in these 38 patients showed 37% positivity for PR pre-neoadjuvant therapy and 21% positivity post-treatment (p=0.03). For 37 patients with HER2 IHC, 32% were positive pre-treatment, and 22% were positive post-treatment (P = 0.20). For 7 patients, HER2 FISH was positive in 71% pre-therapy and in 57% post-treatment (P=0.32).Conclusions
Profiles for ER, HER2 IHC, and HER2 FISH were not significantly different in primary breast carcinomas before and after neoadjuvant chemotherapy. Further investigation is warranted to assess reproducibility of technique and investigate clinical implications of significant loss of PR status in treated patients. 相似文献26.
27.
When performing skin biopsy using the skin biopsy punch, it is recommended that Terson lens capsule forceps be used as an aid to avoid crush artifact. This is because secure yet gentle purchase of the specimen is allowed by a row of small inwardly directed tines that arise from the 2.5 mm horizontally placed grasping blades, which are inserted into the incision created by a 3mm biopsy punch. The instrument also has the extra advantages of being in the correct working position when held with the hand in the resting position between prone and supine, of allowing an uninterrupted line of vision to the wound during use and is of a shape that minimizes unintentional contact with tissue. 相似文献
28.
The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates. 总被引:1,自引:0,他引:1
Danny Goldstein Taher Nassar Gregory Lambert Jean Kadouche Simon Benita 《Journal of controlled release》2005,108(2-3):418-432
In an attempt to design a targeted drug delivery system to tumors' over-expressing H-ferritin specifically recognized by a monoclonal antibody, AMB8LK, a cationic emulsion - AMB8LK conjugate was prepared. A novel cross-linker molecule bearing maleimide group was synthesized and added to cationic emulsion formulation for AMB8LK Fab' fragment covalent coupling. NMR spectroscopy confirmed the cross-linker synthesis and the preservation of the active maleimide function. SDS gel-electrophoresis results corroborated the formation of the Fab' fragment. Different densities of Fab' fragments (10-200 Fab'/oil droplet) were conjugated to emulsion droplet interface and no changes in the physico-chemical properties were observed ( approximately 120 nm size and zeta potential of approximately +30 mV). The coupling efficiency ranged from 55% to 70% and was visualized by TEM showing gold particles attached to the droplet interface. Cell culture studies demonstrated specific binding to cells as confirmed by the occurrence of the marked reduction in binding when free AMB8LK Mab was incubated before adding the AMB8LK-emulsion conjugate to the cells. The coupling of AMB8LK Fab' fragment to the cationic emulsion increased the cells uptake by 50% as compared to non-conjugated respective cationic emulsion. Appropriate conditions were, thus, identified for coupling AMB8LK Fab' fragment to cationic emulsion without altering the specificity and affinity of the Mab fragment to the tumor antigen. 相似文献
29.
30.